FierceBiotechOriginal article
{"a":[{"_":"Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier","$":{"href":"/biotech/novartis-pays-sironax-125m-acquire-platform-crossing-blood-brain-barrier","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Novartis has acquired Sironax's blood-brain barrier crossing platform for $125 million, gaining control of technology to deliver large molecules to central nervous system targets.
Importance:7/10
Sentiment:
0.60
acquisitionblood-brain barrierCNSplatform technologydrug delivery
Related Companies
Read the original article
Published by FierceBiotech on September 16, 2026 8:32 AM
